Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677337 · ClinicalTrials.gov registry record · NA
NCCN Renal Cell Registry
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT02677337 is a NA study that has completed, run by Duke University. The registered enrollment target is 120 participants.
The verdict
NCT02677337, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will consist of three parts: 1) a retrospective chart review of patients treated for mRCC from July 2013 until the start of the educational intervention; 2) an educational program for DCN community oncology providers and DCN community patients with mRCC, lasting 8 - 10 months, and 3) a second retrospective chart review of patients treated for mRCC starting at the time of the educational intervention until the intervention is completed.
Interventions
- OTHER chart abstraction
- OTHER Educational Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02677337
The ClinicalTrials.gov registry entry for NCT02677337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which chart abstraction is the first listed.
NCT02677337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02677337 about?
NCT02677337 is a clinical study titled "NCCN Renal Cell Registry". This study will consist of three parts: 1) a retrospective chart review of patients treated for mRCC from July 2013 until the start of the educational intervention; 2) an educational program for DCN community oncology providers and DCN community patients with mRCC, lasting 8 - 10 months, and 3) a se...
What is the current status of trial NCT02677337?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2016-03. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02677337?
The interventions under investigation include: chart abstraction (OTHER), Educational Program (OTHER).
Who is sponsoring clinical trial NCT02677337?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.